FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to medicine and aims at treating and preventing hepatic encephalopathies. There are presented composite formulations containing various combinations of L-carnitine, acetyl-L-carnitine, succinate, L-glutamate, L-arginine, betaine and creatine phosphate, N-acetylcysteine, coenzyme Q10 and dihydroquercetin; S-adenosylmethionine; coenzyme Q10 and dihydroquercetin, dihydroquercetin and lipoamide.
EFFECT: group of inventions enables relieving behavioural, neurological and psychic disorders by activating the osmoprotective and energetic systems, detoxification reaction systems of ammonium ions and other toxins, as well as the antioxidant systems of cerebral and hepatic cells.
5 cl, 3 ex, 4 tbl, 3 dwg
Title | Year | Author | Number |
---|---|---|---|
HEPATOPROTECTIVE AND ANTIHEPATOTOXIC PHARMACEUTICAL COMPOSITION AND METHOD OF TREATING HEPATIC DISEASES THAT INVOLVES INTRODUCTION OF SAID COMPOSITION | 2008 |
|
RU2381800C1 |
METHOD OF TREATING ACUTE HEPATIC IMPAIRMENT | 2018 |
|
RU2701792C1 |
METHOD OF THE TREATMENT OF THE BRAIN IN ACUTE HYPOXIA WITH HYPERCAPNIA | 2022 |
|
RU2803387C1 |
AGENT ELICITING HEPATOPROTECTIVE AND ANTI-ENCEPHALOPATHIC PROPERTY FOR REDUCING ALCOHOLIC INTOXICATION, PROPHYLAXIS AND REMOVING ALCOHOLIC INTOXICATION AND WITHDRAWAL SYNDROME | 2004 |
|
RU2254858C1 |
PHARMACEUTICAL COMPOSITION FOR TREATING ASTHENIA AND/OR CHRONIC FATIGUE SYNDROME | 2014 |
|
RU2578412C1 |
METHOD OF TREATING HEPATIC FAILURE | 2015 |
|
RU2586952C1 |
METHOD OF TREATING CEREBRAL OEDEMA IN PATIENTS SUFFERING FROM CHRONIC LIVER DISEASES | 2014 |
|
RU2539139C1 |
NATURAL PHOSPHOLIPID AGENT | 2008 |
|
RU2367443C1 |
COMBINATIONS OF PALMITOYLETHANOLAMIDE FOR TREATING CHRONIC PAIN | 2018 |
|
RU2701720C1 |
STEROID COMPOUND FOR USE IN TREATMENT OF HEPATIC ENCEPHALOPATHY | 2015 |
|
RU2684616C2 |
Authors
Dates
2013-08-27—Published
2011-03-16—Filed